Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 14, 2019

SELL
$94.85 - $109.54 $1.89 Million - $2.19 Million
-19,949 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$98.13 - $108.9 $1.96 Million - $2.17 Million
19,949 New
19,949 $2.17 Million
Q2 2018

Aug 14, 2018

SELL
$96.1 - $103.24 $2.04 Million - $2.2 Million
-21,265 Closed
0 $0
Q1 2018

May 15, 2018

SELL
$92.16 - $103.8 $8.51 Million - $9.58 Million
-92,300 Reduced 81.28%
21,265 $2.08 Million
Q4 2017

Feb 14, 2018

SELL
$85.26 - $94.62 $2.07 Million - $2.3 Million
-24,300 Reduced 17.63%
113,565 $10.5 Million
Q3 2017

Nov 14, 2017

BUY
$79.29 - $88.45 $10.9 Million - $12.2 Million
137,865
137,865 $11.8 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $151B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Endurant Capital Management LP Portfolio

Follow Endurant Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Endurant Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Endurant Capital Management LP with notifications on news.